Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Sep 1, 2015

30339_dirs_2015-09-01_d84bfb72-a94f-40ea-9565-6e4208c05dcf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-08-28

Reporting Person: Flynn Karen (President, Pharma Pckg Systems)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-28 Common Stock A 10.4637 $56.8600 Acquired 1025.1237 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 24609.8300 Direct
Common Stock 311.7300 Indirect